Letter to the Editor: Examining HBV‐RNA Kinetics During NA Treatment—Are NAs Multifunctional Antiviral Agents?
Open Access
- 3 June 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Hepatology
- Vol. 74 (3) , 1708-1709
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Analysis of HBsAg levels, HBsAg isoforms, HBsAg immune complexes, HBV pregenomic RNA and HBcrAg dynamics during and after NAP-based combination therapy in the REP 301-LTF and REP 401 studiesJournal of Hepatology, 2020
- Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg‐positive chronic hepatitis B treated with nucleos(t)ide analoguesAlimentary Pharmacology & Therapeutics, 2020
- Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue TherapyHepatology, 2019
- Modeling complex decay profiles of hepatitis B virus during antiviral therapy†‡Hepatology, 2008